Use access key #2 to skip to page content.
$4.78 0.16 (3.46%)
7/8/2008 4:00 PM

Repligen Corp (RGEN)

CAPS Rating:
****

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating RGEN

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

243 Outperforms
9 Underperforms
 

All-Stars

53 Outperforms
2 Underperforms
 

Wall Street

1 Outperforms
0 Underperforms
 

Players bullish on RGEN are also bullish on:

Players bearish on RGEN are also bearish on:

Ticker Tags

Micro Cap (4824), Biotechnology (293)
Suggest a tag

Repligen Corp At A Glance

Current Price: $4.78
Last Trade Time: 7/8/2008 4:00 PM
Open: $0.00
Previous Close: $4.78
Daily Range: $4.54 - $4.78
52-Week Range: $3.53 - $6.93
Volume: 111,285
Market Cap: $149.00M
P/E Ratio: 3.98
Compare Our Special Broker Offers!

Stock Trends

RGEN VS S&P 500 (SPY)

RGEN 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for RGEN

More Headlines...

Top Bull Pitch

Recs

2

Repligen Corp (RGEN)

Avatar carolchris95 (34.95) Submitted: 3/31/08 11:26 AM

Repligen Corp. is filling a voild with it's research and products.


This stock has an excellent PE ratio and a good profit margin.


I see this stock hiiting the $10 -12 for share within 18 months.


Maybe sooner depending the results of the clinical trials.

Replies: 2 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 44 :   1 2 3 4 5 Next »

Recs

0

 (RGEN)

Avatar darksider389 (< 20) Submitted: 6/22/08 1:07 PM : Outperform Start Price: $4.90 RGEN Score: 1.25

Buy back.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RGEN)

Avatar cronsmith (41.78) Submitted: 6/01/08 10:25 PM : Outperform Start Price: $5.73 RGEN Score: -7.55

Undervalued. Good Fundamentals.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RGEN)

Avatar TMFStockpick08 (< 20) Submitted: 5/27/08 9:43 AM : Outperform Start Price: $5.81 RGEN Score: -10.14

This stock was picked by TMFOrangeblood for the 2008 Stockpicking Contest.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RGEN)

Avatar Matigrje (< 20) Submitted: 5/21/08 11:24 PM : Outperform Start Price: $5.91 RGEN Score: -10.40

Small medical research company that is one of the leaders in finding treatments for bi-polar disorders. Stock price is low with room to climb.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (RGEN)

Avatar maxumtrades (44.32) Submitted: 5/21/08 8:33 PM : Outperform Start Price: $5.91 RGEN Score: -10.40

RGEN has solid fanacials and is currently climbing at a slow rate. Good pharmaceutic
This stock has a bright future and is gaining support from the 10ma.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 44 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 1 of 1  

picks per page. CHANGE

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRodmanRen < 20 04/12/07 04/12/07 Outperform NS $3.52+35.80%-11.51%+47.30

Results 1 - 1 of 1  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners